Tamblyn R, Habib B, Buckeridge D, Weir D, Frolova E, Alattar R
BMJ Open. 2024; 14(11):e084492.
PMID: 39581737
PMC: 11590805.
DOI: 10.1136/bmjopen-2024-084492.
Newport K, Langford A, McEvoy A, Kelly D, Smith T, Tannenbaum C
Can Pharm J (Ott). 2024; 157(4):164-170.
PMID: 39092083
PMC: 11290586.
DOI: 10.1177/17151635241246975.
Pierson T, Arcand V, Farrell B, Gagnon C, Leung L, McCarthy L
Drug Saf. 2024; 47(9):829-839.
PMID: 38884849
PMC: 11324714.
DOI: 10.1007/s40264-024-01444-2.
Turner J, Halme A, Caetano P, Langford A, Tannenbaum C
JAMA Netw Open. 2024; 7(5):e2413698.
PMID: 38809554
PMC: 11137632.
DOI: 10.1001/jamanetworkopen.2024.13698.
Turner J, Newport K, McEvoy A, Smith T, Tannenbaum C, Kelly D
Can Pharm J (Ott). 2024; 157(3):133-142.
PMID: 38737354
PMC: 11086729.
DOI: 10.1177/17151635241240737.
Efficacy and Safety of Transitioning to Lemborexant from Z-drug, Suvorexant, and Ramelteon in Japanese Insomnia Patients: An Open-label, Multicenter Study.
Ozone M, Hirota S, Ariyoshi Y, Hayashida K, Ikegami A, Habukawa M
Adv Ther. 2024; 41(4):1728-1745.
PMID: 38460107
PMC: 10960898.
DOI: 10.1007/s12325-024-02811-2.
Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER).
Mangin D, Lamarche L, Templeton J, Salerno J, Siu H, Trimble J
Drugs Aging. 2023; 40(9):857-868.
PMID: 37603255
PMC: 10450010.
DOI: 10.1007/s40266-023-01055-z.
A Proposed Curricular Framework for an Interprofessional Approach to Deprescribing.
Farrell B, Raman-Wilms L, Sadowski C, Mallery L, Turner J, Gagnon C
Med Sci Educ. 2023; 33(2):551-567.
PMID: 37261023
PMC: 10226933.
DOI: 10.1007/s40670-022-01704-9.
Alliance for Sleep Clinical Practice Guideline on Switching or Deprescribing Hypnotic Medications for Insomnia.
Watson N, Benca R, Krystal A, McCall W, Neubauer D
J Clin Med. 2023; 12(7).
PMID: 37048577
PMC: 10095217.
DOI: 10.3390/jcm12072493.
Team-based primary care reforms and older adults: a descriptive assessment of sociodemographic trends and prescribing endpoints in two Canadian provinces.
Austin N, Rudoler D, Allin S, Dolovich L, Glazier R, Grudniewicz A
BMC Prim Care. 2023; 24(1):7.
PMID: 36627566
PMC: 9832790.
DOI: 10.1186/s12875-022-01960-z.
(C)onsumer focused (E)ducation on p(A)racetamol (S)ide (E)ffects, i(N)adequate (O)utcomes and (W)eaning (CEASE NOW) for individuals with low back pain: results of a feasibility study.
Patterson T, Turner J, Gnjidic D, Mintzes B, Bennett C, Bywaters L
BMJ Open. 2022; 12(11):e068164.
PMID: 36424116
PMC: 9693669.
DOI: 10.1136/bmjopen-2022-068164.
Interventions to address potentially inappropriate prescriptions and over-the-counter medication use among adults 65 years and older in primary care settings: protocol for a systematic review.
Beck A, Persaud N, Tessier L, Grad R, Kidd M, Klarenbach S
Syst Rev. 2022; 11(1):225.
PMID: 36266708
PMC: 9585747.
DOI: 10.1186/s13643-022-02044-w.
Influencers on deprescribing practice of primary healthcare providers in Nova Scotia: An examination using behavior change frameworks.
Kennie-Kaulbach N, Cormier R, Kits O, Reeve E, Whelan A, Martin-Misener R
Med Access Point Care. 2022; 4:2399202620922507.
PMID: 36204093
PMC: 9413600.
DOI: 10.1177/2399202620922507.
Deprescribing practices in Canada: A scoping review.
Desai M, Park T
Can Pharm J (Ott). 2022; 155(5):249-257.
PMID: 36081917
PMC: 9445505.
DOI: 10.1177/17151635221114114.
Motivating deprescribing conversations for patients with Alzheimer's disease and related dementias: a descriptive study.
Antonelli M, Cox J, Saphirak C, Gurwitz J, Singh S, Mazor K
Ther Adv Drug Saf. 2022; 13:20420986221118143.
PMID: 36052398
PMC: 9425903.
DOI: 10.1177/20420986221118143.
[Medication safety during the COVID-19 pandemic in primary care nurses].
Escandell Rico F, Perez Fernandez L
Aten Primaria. 2022; 54(6):102352.
PMID: 35525081
PMC: 8938186.
DOI: 10.1016/j.aprim.2022.102352.
[Perception of the safe administration of medications in primary care].
Escandell Rico F, Perez Fernandez L
Aten Primaria. 2022; 54(5):102348.
PMID: 35468340
PMC: 9052062.
DOI: 10.1016/j.aprim.2022.102348.
"Talking About Your Medications": A workshop series aimed at helping older adults participate in conversations about their medications.
Farrell B, Dilliott D, Richardson L, Conklin J, McCarthy L, Raman-Wilms L
Can Pharm J (Ott). 2022; 155(2):86-92.
PMID: 35300023
PMC: 8922225.
DOI: 10.1177/17151635221076075.
Attitudes Toward Deprescribing in Older Adults and Caregivers: A Survey in Quebec, Canada.
Rakheja B, Sirois C, Ouellet N, Roux B, Laroche M
J Appl Gerontol. 2022; 41(5):1376-1384.
PMID: 35246001
PMC: 9024025.
DOI: 10.1177/07334648211069553.
Deprescribing of non-antiretroviral therapy in HIV-infected patients.
Blanco J, Morillo R, Abril V, Escobar I, Bernal E, Folguera C
Eur J Clin Pharmacol. 2019; 76(3):305-318.
PMID: 31865412
DOI: 10.1007/s00228-019-02785-z.